[Treatment and prevention of Staphylococcus aureus].
The number of Staphylococcus aureus (S. aureus) community and nosocomial acquired infections have increased in the last twenty years. Between 1990 and 1992, this pathogen has become the most frequent source of nosocomial infections 1,2. On the other hand, as result of antibiotherapy selection pressure, we observe a dramatic increase in the methicillin-resistant S. aureus (MRSA) infections 3,4. With the recent emergence of multiresistant strains, including glycopeptides resistance, the treatment of these infections became still more difficult 2,4-6. It's important to prevent resistant strains emergence. To prevent further emergence of resistant strains, the use of antibiotherapy must be optimised, laboratory methods for the detection of resistant pathogens must be enhanced and strict precautions should be taken following of the infection or colonization of patients 6-10. In this paper, we review anti-staphylococci history evolution and point out the present recommendations for the treatment and prevention of Staphylococcus aureus infections and colonization.
Ribeiro
Isabel
I
Interna Complementar de Nefrologia, Serviço de Medicina Interna B do Hospital de São João.
Castanheira
Rui
R
D017714:Community-Acquired Infections / Q000628:therapy; D003428:Cross Infection / Q000628:therapy; D006801:Humans; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000628:therapy*; D013211:Staphylococcus aureus / Q000187:drug effects